You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Claims for Patent: 10,017,732


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,017,732
Title:Cell culture compositions with antioxidants and methods for polypeptide production
Abstract:Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided.
Inventor(s):Vijayasankaran Natarajan, Meier Steven J., Varma Sharat, Yang Yi
Assignee:GENENTECH, INC.
Application Number:US14211416
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,017,732

Details for Patent 10,017,732

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 February 19, 2002 ⤷  Get Started Free 2034-03-14
Genentech, Inc. AVASTIN bevacizumab Injection 125085 February 26, 2004 ⤷  Get Started Free 2034-03-14
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 June 30, 2006 ⤷  Get Started Free 2034-03-14
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 August 10, 2012 ⤷  Get Started Free 2034-03-14
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 October 13, 2016 ⤷  Get Started Free 2034-03-14
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 March 20, 2018 ⤷  Get Started Free 2034-03-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 10,017,732

Country Patent Number Estimated Expiration
South Africa 201805630 ⤷  Get Started Free
South Africa 201506155 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2014145098 ⤷  Get Started Free
United States of America 2024400976 ⤷  Get Started Free
United States of America 2021017488 ⤷  Get Started Free
United States of America 2019144817 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.